Program ICLB/ESGBOR symposium
The 2021 virtual ICLB/ESGBOR symposium on Lyme borreliosis: from ecology to prevention
17:00
Introduction by the chairs
Board ESGBOR Board - Volker Fingerle, Anna Henningsson, Mateusz Markowicz & ILCB ICLB2022 chairs - Joppe Hovius, Hein Sprong
17:05
17:30
Q&A
17:40
The new IDSA guideline, a European perspective
Franc Strle (University Medical Center Ljubljana, Ljubljana, Slovenia)
18:05
Q&A
18:15
Break & musical Intermezzo
Info musical Intermezzo - Passacaglia van Händel-Halvorsen en Duo’s van Reinhold Glière
Laura Oomens & Anastasia Feruleva
18:25
Development of a multivalent OspA based Lyme vaccine: Update on Phase 2 clinical studies in healthy adults
Nicole Bezay (Valneva, Saint-Herblain, France)
Nicole Bézay, PhD, is Director Clinical Strategy at Valneva, a speciality vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases. She is the clinical lead for a new multivalent Lyme borreliosis vaccine candidate, which is currently in clinical Phase 2 testing.

18:50
Q&A
19:00
Closure